TABLE 3.
Incidence of Structural Ocular Complications and of Visual Acuity Loss in HLA-B27-Associated Uveitis
| Event | n/Na | Rate/EY (95% CI)b |
|---|---|---|
| Any ocular complication | 21/53 | 0.224 (0.146–0.344) |
| Elevated intraocular pressure (> 21 mm Hg) | 25/102 | 0.102 (0.069–0.151) |
| Posterior Subcapsular Cataracts (≥ trace opacity) | 20/99 | 0.091 (0.059–0.143) |
| Posterior Synechaie | 12/89 | 0.053 (0.030–0.094) |
| Epiretinal Membrane | 7/109 | 0.022 (0.011–0.047) |
| Cystoid Macular Edema | 5/109 | 0.016 (0.007–0.039) |
| Band Keratopathy | 3/109 | 0.010 (0.003–0.030) |
| Hypotony (< 6 mm Hg) | 2/110 | 0.006 (0.001–0.025) |
| Vision Loss 20/50 or worse | 15/92 | 0.062 (0.037–0.102) |
| Vision Loss 20/200 or worse | 7/100 | 0.023 (0.011–0.049) |
a
Number of events/Number of eyes at risk
b
Incidence rate is number of events in an affected eye per eye-years at risk